Medicare Enrolled

Dr. Mary Moore, M.D.

Dermatology · Missouri City, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7435 HIGHWAY 6 STE B, Missouri City, TX 77459
8323429700
In practice since 2007 (18 years)
NPI: 1134314263 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Moore from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Moore? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Moore

Dr. Mary Moore is a dermatology specialist in Missouri City, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Moore performed 1,896 Medicare services across 1,117 unique beneficiaries.

Between the years covered by Open Payments, Dr. Moore received a total of $36,615 from 49 pharmaceutical and/or device companies across 1516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Moore is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 1,896 Medicare services $36,615 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,896
Medicare services
Bottom 45% in TX for dermatology
1,117
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~105 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 618 $5 $14
Office visit, established patient (20-29 min) 503 $57 $178
Destruction of precancerous skin growth, 1 221 $37 $161
Destruction of skin growths (warts/lesions), 1-14 191 $76 $266
Skin biopsy, tangential 104 $60 $184
New patient office visit (30-44 min) 96 $64 $262
Office visit, established patient (10-19 min) 60 $37 $106
Office visit, established patient (30-39 min) 47 $84 $262
New patient office or other outpatient visit, 15-29 minutes 22 $40 $181
Destruction of skin growth, 15 or more growths 19 $90 $316
Biopsy of related skin growth, each additional growth 15 $38 $100
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$36,615
Total received (2018-2024)
Avg $5,231/year across 7 years
Top 9% in TX for dermatology
49
Companies
1,516
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,053 (57.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,212 (41.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$350 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,995
2023
$4,242
2022
$4,139
2021
$2,940
2020
$2,052
2019
$3,657
2018
$15,590

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Galderma Laboratories, L.P.
$14,390
Janssen Biotech, Inc.
$2,500
ABBVIE INC.
$1,914
Regeneron Healthcare Solutions, Inc.
$1,827
MAYNE PHARMA INC.
$1,633
Novartis Pharmaceuticals Corporation
$1,244
PFIZER INC.
$1,020
Mayne Pharma Inc.
$1,003
Encore Dermatology Inc.
$847
Incyte Corporation
$804
Amgen Inc.
$771
Lilly USA, LLC
$661
Allergan, Inc.
$648
Dermavant Sciences, Inc.
$643
Paratek Pharmaceuticals, Inc.
$618
GENZYME CORPORATION
$547
E.R. Squibb & Sons, L.L.C.
$460
LEO Pharma Inc.
$443
AbbVie, Inc.
$417
Ortho Dermatologics, a division of Bausch Health US, LLC
$392
AbbVie Inc.
$370
VYNE Pharmaceuticals Inc.
$365
Sun Pharmaceutical Industries Inc.
$355
Medimetriks Pharmaceuticals, Inc.
$350
MAYNE PHARMA COMMERCIAL LLC
$326
UCB, Inc.
$280
Journey Medical Corporation
$266
Celgene Corporation
$257
Arcutis Biotherapeutics, Inc.
$155
Almirall LLC
$155
Allergan Inc.
$143
Janssen Scientific Affairs, LLC
$92
DERMIRA, INC.
$79
EPI Health, LLC
$76
Taro Pharmaceuticals USA, Inc.
$68
Merck Sharp & Dohme Corporation
$65
SUN PHARMACEUTICAL INDUSTRIES INC.
$60
Boehringer Ingelheim Pharmaceuticals, Inc.
$53
STRATA Skin Sciences, Inc.
$51
Exeltis, USA Inc.
$43
Bayer HealthCare Pharmaceuticals Inc.
$33
Sebela Pharmaceuticals Inc.
$31
Hill Dermaceuticals, Inc.
$30
Novum Pharma, LLC
$28
Verrica Pharmaceuticals Inc.
$28
Mylan Pharmaceuticals Inc.
$23
Abbott Laboratories
$19
Biofrontera Inc.
$15
Nabriva Therapeutics, plc
$14
Top 3 companies account for 51.4% of total payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Alcortin A · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Ceracade · Cimzia · Clindacin P · Connectivity and Remote care · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Ecoza · Enbrel · Exelderm · FABIOR · FINACEA · Finacea · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · JUBLIA · NUZYRA · OLUMIANT · OPZELURA · ORACEA · Olux · Otezla · PRAMOSONE · QBREXZA · REMICADE · RETIN-A MICRO · RETIN-A-MICRO · RINVOQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TargaDox · Tolak · Tremfya · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · Veltin · Winlevi · XTRAC · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for dermatology in TX.

Equivalent to $1,931 per 100 Medicare services performed
Looking for a dermatology specialist in Missouri City?
Compare dermatologists in the Missouri City area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
226
Per 100K population
26.3
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
6.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Moore is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 9% of TX peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Moore experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Moore performed 618 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Moore receive payments from pharmaceutical companies?
Yes. Dr. Moore received a total of $36,615 from 49 companies across 1,516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Moore's costs compare to other dermatologists in Missouri City?
Dr. Moore's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Moore) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →